Month: May 2020

(All figures are in Canadian dollars, unless otherwise expressed. Exchange rate in Q1 2020: 1.00 CAD = 3.31 BRL)BELO HORIZONTE, Brazil, May 19, 2020 (GLOBE NEWSWIRE) — Verde AgriTech Plc (TSX: “NPK”) (OTCQB: “AMHPF”) (“Verde” or the “Company”) is pleased to announce its financial results for the first quarter ended March 31, 2020 (“Q1 2020”).Q1 2020 FINANCIAL HIGHLIGHTSRevenue increased by 230% to $509,532, compared to $154,279 in Q1 2019.Production increased by 32% with a total of 6,375 tonnes, compared to 4,825 tonnes in Q1 2019.Sales increased by 830% with a total of 10,170 tonnes compared to 1,093 in Q1 2019.Net loss reduced by 9% to $792,195, compared to 872,506 in Q1 2019.“We are encouraged by our continued exponential growth. The first quarter of a calendar year is naturally its weakest for fertilizer demand because...

Charlotte, N.C., May 19, 2020 (GLOBE NEWSWIRE) — Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer (IDM) of patented bulk acoustic wave (BAW) high-band RF filters for mobile and other wireless applications, announced today that management will attend the 17th Annual Craig-Hallum Institutional Investor Conference which will be held virtually on May 27, 2020.Meetings will take place virtually given the ongoing call for social distancing due to the Covid-19 pandemic. Investors that would like to schedule a meeting with Akoustis management should contact their Craig-Hallum sales representative or Akoustis’ investor relations at: ir@akoustis.com.Akoustis has added 13 filters to its product catalog including a 5.6 GHz WiFi filter, a 5.2 GHz WiFi filter, three small cell 5G network...

NEW YORK, May 19, 2020 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced the appointment of Herbert Harris, M.D., Ph.D., as its new Executive Vice President, Translational Medicine, effective May 15, 2020. In this role, Dr. Harris will focus on advancing Tonix’s pre-clinical pipeline, including the potential COVID-19 vaccine into the clinic, as well as participate in Tonix’s ongoing clinical programs.Dr. Gregory Sullivan, Chief Medical Officer of Tonix said, “The recruitment of Dr. Harris to our management team is opportune, arriving at a time Tonix has launched its COVID-19 program and expanded its pipeline of clinical candidates including those in addiction, mood disorders, and geriatric psychiatry. Dr. Harris’ career has exemplified...

GREENWICH, Conn., May 19, 2020 (GLOBE NEWSWIRE) —  XPO Logistics, Inc. (NYSE: XPO), a leading global provider of supply chain solutions, ranks No. 1 in the Fortune 500 category of transportation and logistics for the fourth straight year, as announced by Fortune magazine today. The company ranks No. 196 on the Fortune 500 overall, based on 2019 revenue of $16.6 billion.Bradley Jacobs, chairman and chief executive officer of XPO Logistics, said, “XPO is honored to once again be among the top 200 on the Fortune 500 list and lead the transportation and logistics category. We’re using our strengths to rigorously safeguard our people while keeping goods flowing through supply chains.”In January, Fortune named XPO one of the World’s Most Admired Companies for the third straight year for the quality of the company’s performance and culture.About...

VANCOUVER, British Columbia, May 19, 2020 (GLOBE NEWSWIRE) — Corvus Gold Inc. (“Corvus” or the “Company”) – (TSX: KOR, OTCQX: CORVF) announces that it has initiated geophysical surveys throughout the Mother Lode trend to integrate district scale data into its belt-wide exploration models (Figure 1).  The greatly expanded survey as well as other ongoing regional studies and data compilations are designed to effectively and efficiently unlock the significant potential for new discoveries across the belt and throughout the greater Bullfrog Gold District.  In addition, Corvus has expanded its land position east of AngloGold Ashanti’s new Silicon discovery and north of a new large claim block recently staked by Kinross Gold (Figure 1).  Activity in the belt and the Bullfrog District in general is rapidly expanding with new claim...

Toronto, Ontario, May 19, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Tree of Knowledge International Corp. (CSE: TOKI) (the “Company”) is pleased to announce that it will provide the first Multidisciplinary Post COVID-19 community clinics program through their owned and allied clinics. This planned post COVID-19 multidisciplinary clinical program will primarily start at 14 clinics in Ontario and Nova Scotia followed by expansion to other allied community clinics nationwide.The novel SARS COV-2 virus has affected close to 5 million people worldwide leading to a spectrum of acute COVID-19 presentations from asymptomatic carriers to severe multi-system organ failures and death. As the acute phase of this disease passes, many of recovered patients are showing chronic symptoms like body pain, fatigue or mental wellness...

Highlights include:Drill hole SDD-074; 27.2m @ 3.17 g/t gold and 110 g/t silver,including 4.7m @ 9.75 g/t gold and 416 g/t silverDrill hole SDD-073; 45.4m @ 1.31 g/t gold and 44 g/t silverDrill hole SDD-049; 8.6m @ 3.77 g/t gold and 1004 g/t silver,VANCOUVER, British Columbia, May 19, 2020 (GLOBE NEWSWIRE) — Velocity Minerals Ltd. (TSX.V: VLC) (“Velocity” or the “Company”) announces that it has received results from 26 additional drill holes for the near-surface Sedefche gold project (“Sedefche”), Bulgaria.  Highlights include:Significant mineralization from near surface to depths of approximately 50m from surface:  SDD-074 returned 27.2m @ 3.24 g/t gold (3.17 g/t gold using a 20 g/t top cut) and 110.41 g/t silver.  Top cutting is done when samples return analysis in excess of 20 g/t gold; in this hole 1 sample was top cut from...

WARREN, N.J., May 19, 2020 (GLOBE NEWSWIRE) — Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”) today announced the pricing of offerings for an aggregate of 3,076,923 shares of its common stock at a public offering price of $13.00 per share (the “Offerings”). The Offerings consisted of an underwritten public offering (the “Underwritten Offering”) of 1,923,077 shares and a registered direct offering (the “Direct Offering”) of 1,153,846 shares to an institutional investor affiliated with a member of the Company’s board of directors. Bellerophon has granted the underwriters of the Underwritten Offering a 30-day option to purchase up to an additional 288,461 shares of common stock at the public offering price, less the underwriting discounts and commissions. The gross proceeds to Bellerophon before deducting...

– TIBSOVO® Is the First and Only IDH1 Inhibitor to Be Evaluated in a Phase 3 Clinical Trial for IDH1-Mutant Cholangiocarcinoma –CAMBRIDGE, Mass., May 19, 2020 (GLOBE NEWSWIRE) — Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced that The Lancet Oncology has published data from its global Phase 3 ClarIDHy study of TIBSOVO® (ivosidenib) in previously treated cholangiocarcinoma patients with an isocitrate dehydrogenase 1 (IDH1) mutation. The study met its primary endpoint, demonstrating a statistically significant improvement in progression-free survival (PFS) in patients randomized to TIBSOVO® compared with placebo patients. The safety profile observed in the study was consistent with previously published data. Data from this study were...

MIAMI, May 19, 2020 (GLOBE NEWSWIRE) — Organicell Regenerative Medicine, Inc. (OTCBB:BPSR), a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies, announced today that on May 11, 2020, the U.S. Food and Drug Administration (FDA) authorized two Emergency Compassionate Use Investigational New Drug applications (eINDs), each for a single patient severely ill from COVID-19. These critical patients have received immediate administration of Organicell Flow.Organicell is collaborating with physicians at Landmark Hospital, a network of six hospitals located throughout the Southeast United States, to treat these patients for advanced complications associated with COVID-19. These patients were first treated with Organicell Flow on May 14, 2020 at Landmark Hospital in Athens, GA.   “These two patients...